|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.64 USD | +1.65% |
|
+6.54% | +61.80% |
| Mar. 29 | Guardion Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | North American Morning Briefing : Hopes of March -2- | DJ |
Guardion Health Sciences, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 11.03 million compared to USD 6.95 million a year ago. Revenue was USD 11.05 million compared to USD 7.23 million a year ago.
Net loss was USD 14.92 million compared to USD 24.75 million a year ago. Basic loss per share from continuing operations was USD 14.15 compared to USD 52.23 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +61.80% | 11.1M | |
| +35.01% | 709B | |
| +30.54% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.00% | 239B | |
| +9.21% | 211B | |
| -3.35% | 203B | |
| +10.77% | 171B |
GUARDION HEALTH SCIENCES, INC. 